Location: Home
  • search
  • go
  • Relate News
  • 11/14/2025Recent Executive Moves
  • 11/13/2025Global Pharma and Biotech Leaders Announce New China Investments at CI...
  • 11/13/2025Alcon Expands China Strategy with Focus on Accessibility and Innovatio...
  • 11/13/2025WuXi AppTec Establishes European Headquarters in Munich
  • 11/13/2025Innovative Antibody Therapeutic Development in China Compared with the...
  • 11/11/2025AZ's Evinova and Harbour BioMed Form AI Partnership to Advance Biologi...
  • 11/11/2025MeiraGTx and Eli Lilly Form Strategic Partnership to Advance Gene Ther...
  • 11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...
  • 11/11/2025Nona and Umoja Expand Partnership to Advance In‑Vivo CAR‑T Cell Ther...
  • 11/11/2025Glenmark Gains NMPA Approval for RYALTRIS®
  • 11/11/2025Simcere to Manufacture Idorsia's Insomnia Drug in China
  • 11/11/2025China Launches National Strategy to Integrate AI Across Healthcare Sys...
  • 11/11/2025Chinese Innovative Drug Companies Report Strong Q3 Results
  • 11/11/2025CDE Opens Public Consultation on Draft Guidelines for Recombinant Mono...
  • 11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
  • 11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...
  • 11/7/2025NMPA Pilots Streamlined Review Pathway for Supplemental Applications o...
  • 11/7/2025Recent Executive Moves
  • 11/6/2025Dermavon Files for Hong Kong IPO to Advance Innovative Skin Health Por...
  • 11/6/2025AstraZeneca Adds CNY 990M Investment to Qingdao Inhalants Plant
  • 11/5/2025CSL Behring Expands Partnership with Baiyang Pharma for Albumin Produc...
  • 11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...
  • 11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...
  • 11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...
  • 11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...
  • 11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector
  • 11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading
  • 11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...
  • 11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval
  • Page:3/373 Total number of articles:11185: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group